Last updated on June 2018

Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain


Brief description of study

The overall goal of this imaging trial is to evaluate [18F]PI-2620, a tau targeted positron emission computed tomography radioligand, in individuals with tauopathies and healthy volunteers (HV).

Clinical Study Identifier: NCT03510572

Contact Investigators or Research Sites near you

Start Over

Jae Seung Kim, MD

Asan Medical Center
Seoul, Korea, Republic of
  Connect »